middle.news
How Is AFT Pharmaceuticals Driving 33% Revenue Growth and Global Expansion?
7:41am on Thursday 20th of November, 2025 AEDT
•
Pharmaceuticals
Read Story
How Is AFT Pharmaceuticals Driving 33% Revenue Growth and Global Expansion?
7:41am on Thursday 20th of November, 2025 AEDT
Key Points
33% revenue increase to NZD 114.9 million in 1H FY26
Return to operating profit of NZD 4.7 million from prior loss
International hubs in UK and South Africa to contribute earnings in 2H FY26
R&D investment rises to NZD 9.5 million with progress on intravenous iron and antibiotic eyedrops
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Aft Pharmaceuticals (ASX:AFP)
OPEN ARTICLE